InvAscent
Healthcare
InvAscent-backed RPG Active Pharma buys Raghava Life Sciences' API business
RPG Life Sciences Ltd has agreed to acquire the bulk drugs and intermediates business of Raghava Life Sciences Pvt Ltd, ......
Healthcare
InvAscent-backed Malladi Drugs taps bankers for proposed IPO
Malladi Drugs & Pharmaceuticals Ltd, which counts InvAscent as one of its investors, is preparing to file its draft ......
Healthcare
Are InvAscent, MO Alts beating the benchmark in partial exit from pharma company?
Mid-market private equity firms InvAscent and Motilal Oswal Alternates are partially exiting a pharmaceutical company in......
Healthcare
How InvAscent valued bulk-drugs maker in latest twin deals
Healthcare-focused private equity firm InvAscent is investing in the bulk-drugs subsidiary of a Mumbai-listed company to......
Healthcare
Bottomline: PE-backed Inventia Healthcare returns to growth, turns net cash positive in FY26
Mumbai-based Inventia Healthcare Ltd, a drug development and manufacturing company backed by US-based buyout firm ......
Healthcare
Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays
Sterile injectables manufacturer Maiva Pharma Pvt Ltd, jointly controlled by Morgan Stanley Private Equity Asia and ......
Healthcare
Punjab's Deep Hospital explores first external fundraise, hires banker
Deep Hospital, a multispecialty healthcare centre in Punjab, is exploring its first external fundraise and has appointed......
General
Grapevine: Blackstone, Actis, InvAscent in news
Blackstone is evaluating an initial public offering (IPO) for glass packaging manufacturer PGP Glass, while UK‑based ......
Healthcare
Bottomline: InvAscent-backed Malladi Drugs' FY25 revenue, profit fall amid IPO plans
InvAscent-backed bulk drugs maker Malladi Drugs and Pharmaceuticals Ltd reported a decline in both revenue and net ......
Finance
Flashback 2025: New PE record, large VC vehicles buoy fundraising momentum
India saw a homegrown private equity firm shattering fundraising records for the second year in a row in 2025 while ......









